{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:52:06Z","timestamp":1790124726770,"version":"4.0.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Drug resistance in patients remains a significant obstacle to successful treatment, even with improvements in cancer treatment strategies. Resistance to taxanes, such as docetaxel (Dtx) and cabazitaxel (Cbz), frequently emerges in\n                    <jats:underline>c<\/jats:underline>\n                    astration\n                    <jats:underline>r<\/jats:underline>\n                    esistant\n                    <jats:underline>p<\/jats:underline>\n                    rostate\n                    <jats:underline>c<\/jats:underline>\n                    ancer (CRPC). Through pulse selection of the parental cells (DU145), we established Dtx- and Cbz-resistant CRPC cell models and integrated different omic approaches, including transcriptomics and proteomics, to determine the molecular signatures underlying taxane resistance. Interestingly, several genes were regulated in the same direction (up- or down-regulation) at both the gene and protein expression levels in resistant cells compared to parental cells, suggesting that alterations primarily occur at the transcriptional level and manifest at the protein level. Among the differentially regulated genes, Cysteine Rich Protein 2 (\n                    <jats:italic>CRIP2<\/jats:italic>\n                    ), a gene associated with tumor suppressor function, has been found to be the most downregulated in taxane-resistant cells. Conversely, Nicotinamide N-Methyltransferase (NNMT) exhibited a significant upregulation and has been validated in the context of taxane resistance. Its overexpression was shown to promote taxane resistance in two different CRPC cell lines, whereas depletion via siRNA or gRNA, as well as treatment with 1-methylnicotinamide (1-MNA, used as a feedback inhibitor)resensitized the resistant cells. RNA-sequencing of NNMT-knockout (CRISPR-Cas9) cells has indicated involvement of TGF\u03b2 signaling, and suppressing this pathway has further increased the taxane sensitivity. Epithelial Mesenchymal Transition (EMT) was another pathway depleted upon knockout, and subsequent analysis revealed a significant correlation between NNMT and EMT-related genes (\n                    <jats:italic>VIM<\/jats:italic>\n                    ,\n                    <jats:italic>CDH2<\/jats:italic>\n                    ,\n                    <jats:italic>FN1<\/jats:italic>\n                    ,\n                    <jats:italic>TGFB1<\/jats:italic>\n                    , and\n                    <jats:italic>ZEB2<\/jats:italic>\n                    ) in both the Cancer Cell Line Encyclopedia (CCLE) panel and patient data. Additionally, in cancers other than PC, NNMT has been observed to predict treatment outcomes, and notably, among the patients with a high EMT signature, elevated NNMT levels were associated with decreased overall survival. More importantly, NNMT-high patients were found to be non-responders to taxane-containing chemotherapy regimens. Collectively, our findings suggest that targeting NNMT and the pathways it affects, such as TGF\u03b2, offers a viable approach for addressing taxane-resistant PC.\n                  <\/jats:p>","DOI":"10.1038\/s41420-026-03110-1","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:26:15Z","timestamp":1776425175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nicotinamide N-methyltransferase as a therapeutic target in taxane-resistant castration-resistant prostate cancer"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0437-6385","authenticated-orcid":false,"given":"Buse","family":"Cevatemre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"Karyemez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek","family":"Bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamzah","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"G\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8814-7351","authenticated-orcid":false,"given":"Ahmet Tarik","family":"Baykal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3646-2613","authenticated-orcid":false,"given":"Tugba","family":"Bagci-Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8936-3267","authenticated-orcid":false,"given":"Ceyda","family":"Acilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"3110_CR1","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/biomedicines11030826","volume":"11","author":"NES Jefferi","year":"2023","unstructured":"Jefferi NES, Shamhari AA, Noor Azhar NKZ, Goh Yi Shin J, Mohd Kharir NA, Azhar MA, et al. The role of ER\u03b1 and ER\u03b2 in castration-resistant prostate cancer and current therapeutic approaches. Biomedicines. 2023;11:826.","journal-title":"Biomedicines"},{"key":"3110_CR2","first-page":"57","volume":"10","author":"V Lohiya","year":"2016","unstructured":"Lohiya V, Aragon-Ching JB, Sonpavde G. Role of chemotherapy and mechanisms of resistance to chemotherapy in metastatic castration-resistant prostate cancer. Clin Med Insights: Oncol. 2016;10:57\u201366.","journal-title":"Clin Med Insights: Oncol"},{"key":"3110_CR3","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.3390\/cancers12113323","volume":"12","author":"SM Maloney","year":"2020","unstructured":"Maloney SM, Hoover CA, Morejon\u2011Lasso LV, Prosperi JR. Mechanisms of taxane resistance. Cancers. 2020;12:3323.","journal-title":"Cancers"},{"key":"3110_CR4","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.7150\/thno.44567","volume":"10","author":"Y Li","year":"2020","unstructured":"Li Y, Zhang B, Xiang L, Xia S, Kucuk O, Deng X, et al. TGF-\u03b2 causes Docetaxel resistance in prostate cancer via the induction of Bcl-2 by acetylated KLF5 and protein stabilization. Theranostics. 2020;10:7656\u201370.","journal-title":"Theranostics"},{"key":"3110_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6548","volume":"5","author":"G Galletti","year":"2014","unstructured":"Galletti G, Matov A, Beltran H, Fontugne J, Mosquera JM, Cheung C, et al. ERG induces taxane resistance in castration\u2011resistant prostate cancer. Nat Commun. 2014;5:5548.","journal-title":"Nat Commun"},{"key":"3110_CR6","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tem.2017.02.004","volume":"28","author":"P Pissios","year":"2017","unstructured":"Pissios P. Nicotinamide N\u2011methyltransferase: more than a vitamin B3 clearance enzyme. Trends Endocrinol Metab. 2017;28:340\u201353.","journal-title":"Trends Endocrinol Metab"},{"key":"3110_CR7","doi-asserted-by":"publisher","first-page":"1410479","DOI":"10.3389\/fphar.2024.1410479","volume":"15","author":"W\u2011D Sun","year":"2024","unstructured":"Sun W\u2011D, Zhu X\u2011J, Li J\u2011J, Mei Y\u2011Z, Li W\u2011S, Li J\u2011H. Nicotinamide N\u2011methyltransferase (NNMT): A novel therapeutic target for metabolic syndrome. Front Pharmacol. 2024;15:1410479.","journal-title":"Front Pharmacol"},{"key":"3110_CR8","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/1878-0261.12544","volume":"13","author":"J Li","year":"2019","unstructured":"Li J, You S, Zhang S, Hu Q, Wang F, Chi X, et al. Elevated N\u2011methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform. Mol Oncol. 2019;13:1993\u20132009.","journal-title":"Mol Oncol"},{"key":"3110_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215884","volume":"547","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhou X, Lei Y, Chu Y, Yu X, Tong Q, et al. NNMT contributes to high metastasis of triple-negative breast cancer by enhancing PP2A\/MEK\/ERK\/c\u2011Jun\/ABCA1 pathway-mediated membrane fluidity. Cancer Lett. 2022;547:215884.","journal-title":"Cancer Lett"},{"key":"3110_CR10","first-page":"9195","volume":"15","author":"Z You","year":"2018","unstructured":"You Z, Liu Y, Liu X. Nicotinamide N\u2011methyltransferase enhances the progression of prostate cancer by stabilizing sirtuin 1. Oncol Lett. 2018;15:9195\u2013201.","journal-title":"Oncol Lett"},{"key":"3110_CR11","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.1002\/cam4.4359","volume":"10","author":"S Tahara","year":"2021","unstructured":"Tahara S, Nojima S, Ohshima K, Hori Y, Sato K, Kurashige M, et al. Nicotinamide N\u2011methyltransferase is related to MELF pattern invasion in endometrioid carcinoma. Cancer Med. 2021;10:8630\u201340.","journal-title":"Cancer Med"},{"key":"3110_CR12","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.7314\/APJCP.2014.15.5.2273","volume":"15","author":"Q Jiang","year":"2014","unstructured":"Jiang Q, Yu Y\u2011C, Ding X\u2011J, Luo Y, Ruan H. Bioinformatics analysis reveals significant genes and pathways to target for oral squamous cell carcinoma. Asian Pac J Cancer Prev. 2014;15:2273\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3110_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90019","volume":"2","author":"J Jung","year":"2017","unstructured":"Jung J, Kim LJY, Wang X, Wu Q, Sanvoranart T, Hubert CG, et al. Nicotinamide metabolism regulates glioblastoma stem cell maintenance. JCI Insight. 2017;2:e90019.","journal-title":"JCI Insight"},{"key":"3110_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00509-w","volume":"8","author":"Q Huang","year":"2024","unstructured":"Huang Q, Chen H, Yin D, Wang J, Wang S, Yang F, et al. Multi\u2011omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma. NPJ Precis Oncol. 2024;8:24.","journal-title":"NPJ Precis Oncol"},{"key":"3110_CR15","doi-asserted-by":"publisher","first-page":"45837","DOI":"10.18632\/oncotarget.9962","volume":"7","author":"X Xie","year":"2016","unstructured":"Xie X, Liu H, Wang Y, Zhou Y, Yu H, Li G, et al. Nicotinamide N\u2011methyltransferase enhances resistance to 5\u2011fluorouracil in colorectal cancer cells through inhibition of the ASK1\u2011p38 MAPK pathway. Oncotarget. 2016;7:45837\u201348.","journal-title":"Oncotarget"},{"key":"3110_CR16","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/mc.23209","volume":"59","author":"Y Cui","year":"2020","unstructured":"Cui Y, Yang D, Wang W, Zhang L, Liu H, Ma S, et al. Nicotinamide N\u2011methyltransferase decreases 5\u2011fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect. Mol Carcinog. 2020;59:940\u201354.","journal-title":"Mol Carcinog"},{"key":"3110_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1150-z","volume":"21","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zeng J, Wu W, Xie S, Yu H, Li G, et al. Nicotinamide N\u2011methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Breast Cancer Res. 2019;21:64.","journal-title":"Breast Cancer Res"},{"key":"3110_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41419-024-06422-1","volume":"15","author":"B Cevatemre","year":"2024","unstructured":"Cevatemre B, Bulut I, Dedeoglu B, Isiklar A, Syed H, Bayram OY, et al. Exploiting epigenetic targets to overcome taxane resistance in prostate cancer. Cell Death Dis. 2024;15:132.","journal-title":"Cell Death Dis"},{"key":"3110_CR19","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.3390\/cancers13194985","volume":"13","author":"S Usman","year":"2021","unstructured":"Usman S, Waseem NH, Nguyen TKN, Mohsin S, Jamal A, Teh M-T, et al. Vimentin is at the heart of epithelial\u2013mesenchymal transition (EMT) mediated metastasis. Cancers. 2021;13:4985.","journal-title":"Cancers"},{"key":"3110_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4161\/sgtp.2.1.15114","volume":"2","author":"J Ivaska","year":"2011","unstructured":"Ivaska J. Vimentin: central hub in EMT induction? Small GTPases. 2011;2:51\u201353.","journal-title":"Small GTPases"},{"key":"3110_CR21","doi-asserted-by":"publisher","first-page":"jcs210664","DOI":"10.1242\/jcs.214544","volume":"131","author":"YT Kschonsak","year":"2018","unstructured":"Kschonsak YT, Hoffmann I. Activated ezrin controls MISP levels to ensure correct NuMA polarization and spindle orientation. J Cell Sci. 2018;131:jcs210664.","journal-title":"J Cell Sci"},{"key":"3110_CR22","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.15252\/embr.201642292","volume":"17","author":"F di Pietro","year":"2016","unstructured":"di Pietro F, Echard A, Morin X. Regulation of mitotic spindle orientation: an integrated view. EMBO Rep. 2016;17:1106\u201330.","journal-title":"EMBO Rep"},{"key":"3110_CR23","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.3390\/cancers14174293","volume":"14","author":"A Siltari","year":"2022","unstructured":"Siltari A, Syv\u00e4l\u00e4 H, Lou Y\u2011R, Gao Y, Murtola TJ. Role of lipids and lipid metabolism in prostate cancer progression and the tumor\u2019s immune environment. Cancers. 2022;14:4293.","journal-title":"Cancers"},{"key":"3110_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01437-5","volume":"20","author":"LM Ingram","year":"2021","unstructured":"Ingram LM, Finnerty MC, Mansoura M, Chou C\u2011W, Cummings BS. Identification of lipidomic profiles associated with drug\u2011resistant prostate cancer cells. Lipids Health Dis. 2021;20:15.","journal-title":"Lipids Health Dis"},{"key":"3110_CR25","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/metabo11110765","volume":"11","author":"H Xu","year":"2021","unstructured":"Xu H, Chen Y, Gu M, Liu C, Chen Q, Zhan M, et al. Fatty acid metabolism reprogramming in advanced prostate cancer. Metabolites. 2021;11:765.","journal-title":"Metabolites"},{"key":"3110_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1073\/pnas.1808834116","volume":"116","author":"G Zadra","year":"2019","unstructured":"Zadra G, Ribeiro CF, Chetta P, Ho Y, Cacciatore S, Gao X, et al. Inhibition of de novo lipogenesis targets androgen receptor signaling in castration\u2011resistant prostate cancer. Proc Natl Acad Sci USA. 2019;116:631\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3110_CR27","doi-asserted-by":"publisher","first-page":"e0292483","DOI":"10.1371\/journal.pone.0292483","volume":"18","author":"A Hillowe","year":"2023","unstructured":"Hillowe A, Gordon C, Wang L, Rizzo RC, Trotman LC, Ojima I, et al. Fatty acid binding protein 5 regulates docetaxel sensitivity in taxane\u2011resistant prostate cancer cells. PLoS ONE. 2023;18:e0292483.","journal-title":"PLoS ONE"},{"key":"3110_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","volume":"569","author":"MA Eckert","year":"2019","unstructured":"Eckert MA, Coscia F, Chryplewicz A, Chang JW, Hernandez KM, Pan S, et al. Proteomics reveals NNMT as a master metabolic regulator of cancer\u2011associated fibroblasts. Nature. 2019;569:723\u20138.","journal-title":"Nature"},{"key":"3110_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cytogfr.2023.04.001","volume":"71\u201172","author":"M Turati","year":"2023","unstructured":"Turati M, Mousset A, Issa N, Turtoi A, Ronca R. TGF\u2011\u03b2 mediated drug resistance in solid cancer. Cytokine Growth Factor Rev. 2023;71\u201172:54\u201365.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3110_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603\u20137.","journal-title":"Nature"},{"key":"3110_CR31","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jan\u00e9\u2011Valbuena J, Kryukov GV, Lo CC, McDonald ER, et al. Next\u2011generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019;569:503\u20138.","journal-title":"Nature"},{"key":"3110_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2025.101223","volume":"81","author":"GL Beretta","year":"2025","unstructured":"Beretta GL, Cassinelli G, Rossi G, Azzariti A, Corbeau I, Tosi D, et al. Novel insights into taxane pharmacology: an update on drug resistance mechanisms, immunomodulation and drug delivery strategies. Drug Resist Updates. 2025;81:101223.","journal-title":"Drug Resist Updates"},{"key":"3110_CR33","doi-asserted-by":"publisher","first-page":"8390","DOI":"10.1073\/pnas.1101747108","volume":"108","author":"AKL Cheung","year":"2011","unstructured":"Cheung AKL, Ko JMY, Lung HL, Chan KW, Stanbridge EJ, Zabarovsky E, et al. Cysteine\u2011rich intestinal protein 2 (CRIP2) acts as a repressor of NF\u2011\u03baB\u2011mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis. Proc Natl Acad Sci USA. 2011;108:8390\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3110_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215864","volume":"548","author":"L Wu","year":"2022","unstructured":"Wu L, Ge Y, Yuan Y, Li H, Sun H, Xu C, et al. Genome\u2011wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma. Cancer Lett. 2022;548:215864.","journal-title":"Cancer Lett"},{"key":"3110_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-00966-x","volume":"8","author":"J Wang","year":"2022","unstructured":"Wang J, Liu X, Huang Y, Li P, Yang M, Zeng S, et al. Targeting nicotinamide N\u2011methyltransferase overcomes resistance to EGFR\u2011TKI in non\u2011small cell lung cancer cells. Cell Death Discov. 2022;8:170.","journal-title":"Cell Death Discov"},{"key":"3110_CR36","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3892\/ol.2014.2287","volume":"8","author":"W Zhou","year":"2014","unstructured":"Zhou W, Gui M, Zhu M, Long Z, Huang L, Zhou J, et al. Nicotinamide N\u2011methyltransferase is overexpressed in prostate cancer and correlates with prolonged progression\u2011free and overall survival times. Oncol Lett. 2014;8:1175\u201380.","journal-title":"Oncol Lett"},{"key":"3110_CR37","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1002\/cam4.2890","volume":"9","author":"M Song","year":"2020","unstructured":"Song M, Li Y, Miao M, Zhang F, Yuan H, Cao F, et al. High stromal nicotinamide N\u2011methyltransferase (NNMT) indicates poor prognosis in colorectal cancer. Cancer Med. 2020;9:2030\u20138.","journal-title":"Cancer Med"},{"key":"3110_CR38","doi-asserted-by":"publisher","first-page":"11860","DOI":"10.18632\/aging.205142","volume":"15","author":"Q Wen","year":"2023","unstructured":"Wen Q, Xie X, Chen C, Wen B, Liu Y, Zhou J, et al. Lipid reprogramming induced by the NNMT\u2011ABCA1 axis enhanced membrane fluidity to promote endometrial cancer progression. Aging. 2023;15:11860\u201374.","journal-title":"Aging"},{"key":"3110_CR39","doi-asserted-by":"publisher","first-page":"26200","DOI":"10.18632\/oncotarget.15429","volume":"8","author":"J Kanska","year":"2017","unstructured":"Kanska J, Aspuria P\u2011JP, Taylor\u2011Harding B, Spurka L, Funari V, Orsulic S, et al. Glucose deprivation elicits phenotypic plasticity via ZEB1\u2011mediated expression of NNMT. Oncotarget. 2017;8:26200\u201320.","journal-title":"Oncotarget"},{"key":"3110_CR40","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.neo.2020.09.002","volume":"22","author":"JE Vellky","year":"2020","unstructured":"Vellky JE, Ricke WA. Development and prevalence of castration\u2011resistant prostate cancer subtypes. Neoplasia. 2020;22:566\u201375.","journal-title":"Neoplasia"},{"key":"3110_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/mps8040093","volume":"8","author":"A Asiri","year":"2025","unstructured":"Asiri A, Tasleem M, Al Said M, Asiri A, Al Qarni AA, Bakillah A. Optimizing cell density and unveiling cytotoxic profiles of DMSO and ethanol in six cancer cell lines: experimental and in silico insights. Methods Protoc. 2025;8:93.","journal-title":"Methods Protoc"},{"key":"3110_CR42","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","volume":"32","author":"GY Di Veroli","year":"2016","unstructured":"Di Veroli GY, Fornari C, Wang D, Mollard S, Bramhall JL, Richards FM, et al. Combenefit: an interactive platform for the analysis and visualization of drug combinations. Bioinformatics. 2016;32:2866\u20138.","journal-title":"Bioinformatics"},{"key":"3110_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"3110_CR44","doi-asserted-by":"publisher","first-page":"6014","DOI":"10.3390\/cancers14236014","volume":"14","author":"I Bulut","year":"2022","unstructured":"Bulut I, Lee A, Cevatemre B, Ruzic D, Belle R, Kawamura A, et al. Dual LSD1 and HDAC6 inhibition induces doxorubicin sensitivity in acute myeloid leukemia cells. Cancers. 2022;14:6014.","journal-title":"Cancers"},{"key":"3110_CR45","doi-asserted-by":"publisher","first-page":"114111","DOI":"10.1016\/j.biopha.2022.114111","volume":"158","author":"I Kiris","year":"2023","unstructured":"Kiris I, Kukula\u2011Koch W, Karayel\u2011Basar M, Gurel B, Coskun J, Baykal AT, et al. Proteomic alterations in the cerebellum and hippocampus in an Alzheimer\u2019s disease mouse model: alleviating effect of palmatine. Biomed Pharmacother. 2023;158:114111.","journal-title":"Biomed Pharmacother"},{"key":"3110_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359\u201362.","journal-title":"Nat Methods"},{"key":"3110_CR47","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc Natl Acad Sci USA. 2019;116:11428\u201336.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3110_CR48","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.eururo.2017.08.027","volume":"73","author":"S Ren","year":"2018","unstructured":"Ren S, Wei G\u2011H, Liu D, Wang L, Hou Y, Zhu S, et al. Whole\u2011genome and transcriptome sequencing of prostate cancer identify new genetic alterations driving disease progression. Eur Urol. 2018;73:322\u201339.","journal-title":"Eur Urol"},{"key":"3110_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio Cancer Genomics Portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"3110_CR50","first-page":"132","volume":"29","author":"S Wang","year":"2023","unstructured":"Wang S, Li H, Li M, Liu X, Yu S, Huang H, et al. Role of the KRT7 biomarker in immune infiltration and paclitaxel resistance in ovarian cancer. Altern Ther Health Med. 2023;29:132\u201340.","journal-title":"Altern Ther Health Med"},{"key":"3110_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09370-1","volume":"22","author":"R Tsunedomi","year":"2022","unstructured":"Tsunedomi R, Yoshimura K, Kimura Y, Nishiyama M, Fujiwara N, Matsukuma S, et al. Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cells. BMC Cancer. 2022;22:260.","journal-title":"BMC Cancer"},{"key":"3110_CR52","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1038\/onc.2014.307","volume":"34","author":"HM Itkonen","year":"2015","unstructured":"Itkonen HM, Engedal N, Babaie E, Luhr M, Guldvik IJ, Minner S, et al. UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N\u2011linked glycosylation. Oncogene. 2015;34:3744\u201350.","journal-title":"Oncogene"},{"key":"3110_CR53","doi-asserted-by":"publisher","first-page":"1132424","DOI":"10.3389\/fonc.2023.1132424","volume":"13","author":"J Chen","year":"2023","unstructured":"Chen J, Liu Z, Wu Z, Li W, Tan X. Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer. Front Oncol. 2023;13:1132424.","journal-title":"Front Oncol"},{"key":"3110_CR54","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.3390\/ijms20112750","volume":"20","author":"O Menyh\u00e1rt","year":"2019","unstructured":"Menyh\u00e1rt O, Fekete JT, Gy\u0151rffy B. Gene expression indicates altered immune modulation and signaling pathway activation in ovarian cancer patients resistant to topotecan. Int J Mol Sci. 2019;20:2750.","journal-title":"Int J Mol Sci"},{"key":"3110_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-01985-6","volume":"10","author":"C Wang","year":"2024","unstructured":"Wang C, Dong R, Yang F, Zheng L, Liu Y, Yan Y, et al. LARP4B promotes hepatocellular carcinoma progression and impairs sorafenib efficacy by activating SPINK1-mediated EGFR pathway. Cell Death Discov. 2024;10:208.","journal-title":"Cell Death Discov"},{"key":"3110_CR56","doi-asserted-by":"publisher","first-page":"114542","DOI":"10.1016\/j.ejmech.2022.114542","volume":"239","author":"K Engle","year":"2022","unstructured":"Engle K, Kumar G. Cancer multidrug\u2011resistance reversal by ABCB1 inhibition: a recent update. Eur J Med Chem. 2022;239:114542.","journal-title":"Eur J Med Chem"},{"key":"3110_CR57","doi-asserted-by":"publisher","first-page":"4236","DOI":"10.3390\/cancers15174236","volume":"15","author":"KT Skinner","year":"2023","unstructured":"Skinner KT, Palkar AM, Hong AL. Genetics of ABCB1 in Cancer. Cancers. 2023;15:4236.","journal-title":"Cancers"},{"key":"3110_CR58","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10238-023-01269-w","volume":"24","author":"Q Hao","year":"2024","unstructured":"Hao Q, Liu Y, Liu Y, Shi L, Chen Y, Yang L, et al. Cysteine\u2011 and glycine\u2011rich protein 1 predicts prognosis and therapy response in patients with acute myeloid leukemia. Clin Exp Med. 2024;24:57.","journal-title":"Clin Exp Med"},{"key":"3110_CR59","doi-asserted-by":"publisher","first-page":"3024970","DOI":"10.1155\/2019\/3024970","volume":"2019","author":"K\u2011S Hong","year":"2019","unstructured":"Hong K\u2011S, Kim H, Kim S\u2011H, Kim M, Yoo J. Calponin 3 regulates cell invasion and doxorubicin resistance in gastric cancer. Gastroenterol Res Pract. 2019;2019:3024970.","journal-title":"Gastroenterol Res Pract"},{"key":"3110_CR60","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/1878-0261.13037","volume":"16","author":"C Liverani","year":"2022","unstructured":"Liverani C, De Vita A, Spadazzi C, Miserocchi G, Cocchi C, Bongiovanni A, et al. Lineage\u2011specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture. Mol Oncol. 2022;16:921\u201339.","journal-title":"Mol Oncol"},{"key":"3110_CR61","doi-asserted-by":"publisher","first-page":"12906","DOI":"10.3390\/ijms241612906","volume":"24","author":"I Car","year":"2023","unstructured":"Car I, Dittmann A, Vasieva O, Bo\u010dkor L, Grb\u010di\u0107 P, Pite\u0161a N, et al. Ezrin inhibition overcomes acquired resistance to vemurafenib in BRAFV600E\u2011mutated colon cancer and melanoma cells in vitro. Int J Mol Sci. 2023;24:12906.","journal-title":"Int J Mol Sci"},{"key":"3110_CR62","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2019.05.010","volume":"457","author":"SW Fung","year":"2019","unstructured":"Fung SW, Cheung PF, Yip CW, Ng LW, Cheung TT, Chong CC, et al. The ATP\u2011binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma. Cancer Lett. 2019;457:98\u2013109.","journal-title":"Cancer Lett"},{"key":"3110_CR63","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/15384047.2018.1529091","volume":"20","author":"L Wang","year":"2019","unstructured":"Wang L, Shang X, Feng Q. LncRNA TATDN1 contributes to the cisplatin resistance of non\u2011small cell lung cancer through TATDN1\/miR\u2011451\/TRIM66 axis. Cancer Biol Ther. 2019;20:261\u201371.","journal-title":"Cancer Biol Ther"},{"key":"3110_CR64","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1038\/s41375-024-02343-2","volume":"38","author":"T Terasaki","year":"2024","unstructured":"Terasaki T, Semba Y, Sasaki K, Imanaga H, Setoguchi K, Yamauchi T, et al. The RNA helicases DDX19A\/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells. Leukemia. 2024;38:1918\u201328.","journal-title":"Leukemia"},{"key":"3110_CR65","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1039\/C2MB05512K","volume":"8","author":"AA Seyhan","year":"2012","unstructured":"Seyhan AA, Varadarajan U, Choe S, Liu W, Ryan TE, et al. A genome\u2011wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug-resistant genetic markers. Mol Biosyst. 2012;8:1553\u201370.","journal-title":"Mol Biosyst"},{"key":"3110_CR66","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41419-023-05648-9","volume":"14","author":"W Xie","year":"2023","unstructured":"Xie W, Han Z, Zuo Z, Xin D, Chen H, Huang J, et al. ASAP1 activates the IQGAP1\/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer. Cell Death Dis. 2023;14:124.","journal-title":"Cell Death Dis"},{"key":"3110_CR67","doi-asserted-by":"publisher","first-page":"995","DOI":"10.15252\/embj.201695534","volume":"36","author":"C\u2011W Pan","year":"2017","unstructured":"Pan C\u2011W, Jin X, Zhao Y, Pan Y, Yang J, Karnes RJ, et al. AKT\u2011phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1\u2011MAPK interaction. EMBO J. 2017;36:995\u20131010.","journal-title":"EMBO J"},{"key":"3110_CR68","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1182\/blood.2019001808","volume":"136","author":"RZ Yusuf","year":"2020","unstructured":"Yusuf RZ, S\u00e1ez B, Sharda A, van Gastel N, Yu VWC, Baryawno N, et al. Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers. Blood. 2020;136:1303\u201316.","journal-title":"Blood"},{"key":"3110_CR69","first-page":"1455","volume":"52","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Lu Y, Zhang C, Huang D, Wu W, Zhang Y, et al. FSCN\u20111 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial\u2011mesenchymal transition. Int J Oncol. 2018;52:1455\u201364.","journal-title":"Int J Oncol"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03110-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:03:08Z","timestamp":1779966188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03110-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3110"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03110-1","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval was not required for this study, as the work was based on established cell lines and publicly available online databases, as described in the Materials and Methods, and did not involve human participants, human samples, or animals. Consent to participate was therefore not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"254"}}